In Situ Licensing of Mesenchymal Stem Cell Immunomodulatory Function via BMP-2 Induced Developmental Process

Researchers combined the biological effects of materials with the osteogenic induction capabilities of bone morphogenetic protein (BMP)-2 to develop a unique method for in situ licensing of MSCs’ immunomodulatory function within a controlled inflammatory microenvironment constructed in vivo.